- Business Wire•2 days agoINVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Taro Pharmaceutical Industries Ltd. and Encourages Investors with Losses to Contact the Firm
Khang & Khang LLP announces that it is investigating claims against Taro Pharmaceutical Industries Ltd. concerning possible violations of federal securities laws.
- Business Wire•2 days agoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Taro Pharmaceutical Industries Ltd. and Certain Officers and Directors
Levi & Korsinsky, LLP announces that it has commenced an investigation of Taro Pharmaceutical Industries Ltd. concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.
- PR Newswire•2 days agoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Taro Pharmaceutical Industries Ltd. - TARO
NEW YORK, Oct. 20, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company") (NYSE: TARO) (ISIN: ...
Taro Pharmaceutical Industries Ltd. (TARO)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||103.95 x 200|
|Ask||104.06 x 100|
|Day's Range||102.21 - 105.03|
|52wk Range||101.02 - 157.99|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||8.12|
|Avg Vol (3m)||250,840|
|Dividend & Yield||N/A (N/A)|